Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The British Journal of Dermatology|March 26, 2019
Genome-wide association studies and polygenic risk scores for skin cancer: clinically useful yet?M R Roberts, M M Asgari, A E Toland
Clinical Genetics|June 4, 2013
Linking distant relatives with BRCA gene mutations: potential for cost savingsL Senter, M O'Connor, F Oriyo, et al.
The British Journal of Dermatology|November 1, 2017
The pathogenesis of cutaneous squamous cell carcinoma in organ transplant recipientsC A Harwood, A E Toland, C M Proby, et al.
Human Molecular Genetics|July 1, 1997
Elastin point mutations cause an obstructive vascular disease, supravalvular aortic stenosisD Y Li, A E Toland, B B Boak, et al.
The British Journal of Dermatology|October 11, 2017
Epidemiology of keratinocyte carcinomas after organ transplantationM M Madeleine, N S Patel, E I Plasmeijer, et al.
The British Journal of Dermatology|September 28, 2017
Risk prediction tools for keratinocyte carcinoma after solid organ transplantation: a review of the literatureS E Lowenstein, G Garrett, A E Toland, et al.
The British Journal of Dermatology|April 30, 2017
Variants at the OCA2/HERC2 locus affect time to first cutaneous squamous cell carcinoma in solid organ transplant recipients collected using two different study designsL Wei, D C Allain, M N Bernhardt, et al.
Clinical Genetics|June 21, 2016
EMR documentation of physician-patient communication following genomic counseling for actionable complex disease and pharmacogenomic resultsK Sweet, A C Sturm, T Schmidlen, et al.
Skin Health and Disease|June 9, 2022
Genetic polymorphism in <i>Methylenetetrahydrofolate Reductase chloride transport protein 6</i> (<i>MTHFR CLCN6</i>) gene is associated with keratinocyte skin cancer in a cohort of renal transplant recipientsL Griffin, L Ho, R J Akhurst, et al.
British Journal of Cancer|November 19, 2009
Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)A Osorio, R L Milne, G Pita, et al.
Pageof 2